New Breast Cancer Treatment Approved

Article

WASHINGTON, D.C. - Officials at the Food and Drug Administration (FDA) have approved a new device for treating breast cancer.

The MammoSite Radiation Therapy System is an implanted catheter intended to treat women who had a cancerous lump removed in its early stages of development. The catheter sends radiation directly to the area where the lump was removed, avoiding radiating outlying tissue.

Manufactured by Proxima Therapeutics Inc., of Alpharetta, Georgia, the treatment option may last one to five days and is removed afterward. Although it is intended for all women, some may need whole-breast radiation for complete treatment.

Information from www.reuters.com

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content